• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthPharmaceutical Industry

Scientists rebuke Trump’s Tylenol-autism claim, stress fever is bigger danger in pregnancy

By
Jason Gale
Jason Gale
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Jason Gale
Jason Gale
and
Bloomberg
Bloomberg
Down Arrow Button Icon
September 23, 2025, 8:47 AM ET
Donald Trump
President Donald Trump answers questions after making an announcement on “significant medical and scientific findings for America’s children” in the Roosevelt Room of the White House on September 22, 2025 in Washington, DC. Andrew Harnik/Getty Images

President Donald Trump’s call for pregnant women to avoid Tylenol is drawing sharp criticism from researchers who say the advice ignores decades of evidence and could endanger mothers and babies. 

Recommended Video

At a White House event Monday, Trump linked acetaminophen, the active ingredient in Tylenol, to autism and encouraged women to tough out fevers. The remarks, made alongside health secretary Robert F. Kennedy Jr. — a longtime critic of mainstream medicine — rattled doctors and drugmakers. 

Mady Hornig, a New York physician-scientist who has studied pregnancy-related risk factors for autism and attention deficit hyperactivity disorder for 25 years, said the White House’s message misrepresents the science around acetaminophen, which is also known as paracetamol in Europe and elsewhere.

“It seemed like they had indicated that there was evidence that prolonging a fever is a good thing,” Hornig, a visiting scientist at the Feinstein Institutes for Medical Research, Northwell Health, said in an interview. “It’s astonishing misinformation.” 

Trump and Kennedy have both sought to challenge health guidance and practices, sometimes relying on cherry-picked evidence. The US leader also has a record of promoting unfounded medical theories.

The American College of Obstetricians and Gynecologists called the latest advice on acetaminophen “irresponsible,” while the American Academy of Pediatrics also said misrepresenting science does a “disservice” to autistic people. The UK’s Medicines and Healthcare Products Regulatory Agency said there’s no evidence that paracetamol causes autism and said it remains safe during pregnancy. 

Genetic Risk 

Hornig’s research, based on the Norwegian Mother, Father and Child Cohort Study  of over 100,000 families, found that moderate or high fevers in pregnancy were linked to elevated autism risk, especially in the second trimester. 

“We found that there was about a 40% increased risk of autism without acetaminophen,” she said. “That went down substantially with the use of acetaminophen.”

She stressed that fever itself, not a single drug, is a key factor. 

“It’s clear that unmitigated fever, particularly where it is of a moderate level or higher, is something that has an impact on offspring to increase risk of autism,” she said. “To allow women to have even a modest fever during pregnancy, which in and of itself can potentially cause damage and is associated in many studies with risk, is very worrisome.”

In preliminary, unpublished work, Hornig’s team also saw hints that acetaminophen taken for pain may carry different risks. “There seems to be some pattern that suggested that for pain, it may not be the drug to use,” she added, though she cautioned the findings need more study.

A small number of women reported using ibuprofen for fever during pregnancy. None of their children developed autism, though Hornig stressed the numbers were too small to draw conclusions.

The findings underscore what scientists have long said: autism doesn’t have a single cause. Genetics, timing and environment all interact, Hornig said, citing factors such as parental age gaps, exposure to wildfire smoke and heavy metals, seasonal immune shifts and infections that trigger fever.

“The idea that it’s going to be a singular cause is really kind of foolhardy, and it doesn’t go along with the things that we know,” she said.

Hornig also urged more precision in research. Common genetic differences in enzymes that help break down acetaminophen may influence how safely a pregnant woman can metabolize the drug. Some labs are testing newborns’ meconium for toxic byproducts of acetaminophen metabolism — a potential biomarker that could guide safer choices in the future.

“Our future generations deserve a personalized approach that looks at genetic risk, environmental exposures, and safer alternatives,” she said. 

For now, she said, context matters. Acetaminophen remains widely recommended because aspirin carries a risk of Reye’s syndrome and ibuprofen isn’t considered safe later in pregnancy. But Hornig warned that discouraging treatment altogether — especially with respiratory viruses like flu and Covid-19 still circulating — could leave women vulnerable.

Vaccination before and during pregnancy, when indicated, remains one of the best safeguards against infections that trigger fever, she added.

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Authors
By Jason Gale
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.